Sigma Planning Corp Aytu Biopharma, Inc Transaction History

Sigma Planning Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.19 - $3.8 $3,229 - $64,584	16,996 New	16,996 $3,000
Q1 2022 Apr 20, 2022	SELL	$1.08 - $1.55 $10,925 - $15,679	-10,116 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$1.35 - $2.95 $129 - $283	96 Added 0.96%	10,116 $14,000
Q3 2021 Oct 28, 2021	SELL	$2.78 - $5.12 $4,598 - $8,468	-1,654 Reduced 14.17%	10,020 $29,000
Q2 2021 Aug 13, 2021	BUY	$4.73 - $7.56 $4,502 - $7,197	952 Added 8.88%	11,674 $58,000
Q1 2021 May 06, 2021	BUY	$6.23 - $9.88 $66,798 - $105,933	10,722 New	10,722 $81,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $88.7M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.